TSE:MFC

Manulife Financial (MFC.TO)

57.04
+0.49 (0.87%)
as of Jun 25, 2026, 8:00:00 pm Market Open.
1634 watching
0
Investor Insights
star iconJun 25, 2026, 12:00 am

This summary was created by AI, based on 28 opinions in the last 12 months.

Manulife Financial (MFC) has garnered mixed opinions from market experts. Many analysts recognize MFC's potential, particularly highlighting its growth in Asia and successful capital generation from legacy businesses. The consensus seems to indicate a solid long-term investment due to its steady dividend yield, with several experts suggesting that patience may be required as the stock navigates short-term fluctuations. Despite some concerns about past performance and market positioning against competitors, the company's strategy and management is viewed positively. Analysts mention the current valuation as reasonable compared to peers, suggesting MFC is a better option for income rather than growth. Overall, there is a cautious optimism about MFC's capabilities and future direction.

consensus icon
Consensus
Hold
valuation icon
Valuation
Fair Value
review icon
Similar
SLF-T
WAIT
Basically at a 52-week high. It's at the top of the multiple ranges and had a recent move. Would try to buy it back in the $38 range.
BUY
A great long-term play. Great growth in the US and China.
HOLD
A great company. Fairly reasonably priced, particularly compared to the banks. The premium that insurance companies in general have traded at has shrunk.
BUY
Moderately undervalued according to his valuations. Profit growth rate is better than the market average. Good yield. Stable earnings and ROE history. A relatively defensive interest-rate sensitive name.
TOP PICK
Likes their Hancock acquisition giving exposure to the US, but more important is their Asian positioning. Well run company.
BUY
Has a massively positive franchise in North America. The John Hancock acquisition has been well integrated. Likes their Asian exposure. Expects to see solid earnings growth in future.
BUY
In terms of using financial services to access greater Asian exposure this is a company you might want to consider.
HOLD
One of his favourite companies, but wouldn't be putting new money into it. On a relative valuation basis, Sun Life (SLF-T) is a little bit better buy at this point in time.
BUY
Of all the financials, this one has the nicest chart. The banks all did fairly well with 10%-20% returns. This one did not have the same returns and has some catching up to do. Had a number of bottoms from June on and they were always higher. Also had a pretty steady top with a nice breakout in November.
PAST TOP PICK
(A Top Pick Dec 28/05. Up 15.2%.) Still likes, but sold his holdings. If you want to be in this space, use Sun Life (SLF-T).
WAIT
Probably fully priced here and would let it consolidate. Good solid company. Expecting a market correction in the next 2 to 3 months.
BUY
Favourite life insurance company in North America. Best prospects to grow. Expect them to make a major acquisition in the US to further their growth. The big kicker is their far east operations.
TOP PICK
(A Top Pick July 4/06. Up 6.8%.) A bit disappointed that they have lagged the financial group. A great company. Earnings next year will probably be double the growth rate of the banks. Management is superb. Well diversified globally.
DON'T BUY
Broadly speaking, the financial area is extended and this is one that is more extended. It would be nice if they came up with another great idea, which would move it a bit.
BUY
Has some good growth prospects. Have made some astute acquisitions. Good dividend and solid earnings. 2% dividend.
Showing 1,831 to 1,845 of 2,281 entries